Private Equity
Jaguar Ventures is seeking to raise $25 million for its second fund, according to an SEC filing. The Mexican venture firm targets early-stage investments in Latin America.
1 min read · 07 June 2019
A weekly letter from the VCJ editor about items heard-on-the-grapevine, recent event happenings, data and a look ahead to what’s coming up
4 min read · 07 June 2019
The Shatter Fund, which invests in women-led tech companies, is seeking to raise $10 million for its debut fund, according to a regulatory filing. The filing lists the fund's address as Danville, California. The firm is led by Shelly Kapoor Collins, founding partner of the firm.
1 min read · 06 June 2019
1 min read · 06 June 2019
ChartSpan, a healthcare managed service provider for chronic care management programs in the U.S., has raised $15 million in Series A funding. BIP Capital led the round with participation from other investors that included Blue Heron Capital, Bailey Southwell & Co., C&B Capital and Service Provider Capital.
1 min read · 06 June 2019
SRI Capital has raised $45.2 million for its debut fund, according to an SEC filing. The target is $100 million. The early-stage venture firm invests in startups mostly based in India and the U.S.
1 min read · 06 June 2019
SRI Capital has raised $45.2 million for its debut fund, according to an SEC filing. The target is $100 million. The early-stage venture firm invests in startups mostly based in India and the U.S.
1 min read · 06 June 2019
TVM Capital Life Science and Caisse de dépôt et placement du Québec (CDPQ) are the 2019 recipients of the Canadian Venture Capital & Private Equity Association's (CVCA) Deal of the Year awards. TVM Capital won in the venture capital category for the 2018 sale of AurKa Pharma, a Montréal-based developer of a cancer treatment for solid tumors, to Eli Lilly. The US$575 million deal generated an IRR of 348 percent and 9.3 x multiple of invested capital. CDPQ won in the private equity category for the 2018 sale of Camso, a Magog, Québec-based maker of off-the-road tires and rubber tracks to Michelin. The transaction was valued at US$1.45 billion.
5 min read · 05 June 2019
TVM Capital Life Science and Caisse de dépôt et placement du Québec (CDPQ) are the 2019 recipients of the Canadian Venture Capital & Private Equity Association's (CVCA) Deal of the Year awards. TVM Capital won in the venture capital category for the 2018 sale of AurKa Pharma, a Montréal-based developer of a cancer treatment for solid tumors, to Eli Lilly. The US$575 million deal generated an IRR of 348 percent and 9.3 x multiple of invested capital. CDPQ won in the private equity category for the 2018 sale of Camso, a Magog, Québec-based maker of off-the-road tires and rubber tracks to Michelin. The transaction was valued at US$1.45 billion.
5 min read · 05 June 2019
The federal government’s Venture Capital Catalyst Initiative (VCCI) has committed $50 million to ArcTern Ventures, Cycle Capital Management and Renewal Funds, all Canadian venture capital firms active in the clean technology sector. Montréal-based Cycle and Vancouver-based Renewal will receive $20 million apiece, the Globe and Mail reported, while Toronto-based ArcTern will get $10 million. ArcTern initially closed its second fund last year, raising $60 million, while Cycle initially closed its fourth fund in February, raising $109 million. VCCI, a $400 million program to shore up venture capital supply in Canada, in 2018 secured an additional $50 million from Ottawa earmarked for clean technology.
3 min read · 05 June 2019
